SEC Form 4 · accession 0001181431-15-004662
VivoSim Labs, INC. · VIVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Collins Presnell
Officer — EVP, Research & Dev & CTO
Period of report
Mar 12, 2015
Accepted (ET)
Mar 16, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001497253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 12, 2015 | M | 50,000 | $0.08 | A | 74,064 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $0.08 | Mar 12, 2015 | M | 50,000 | D | — | Oct 13, 2021 | Common Stock | 50,000 | 622,192 | D |
Explanation of responses
- F1Represents shares acquired pursuant to the exercise of a previously granted stock option.
- F2This number does not include 1,052,192 shares of common stock underlying outstanding options held by Dr. Presnell; post-transaction Dr. Presnell continues to beneficially own or have a right to acquire 1,126,256 shares of common stock.
- F325% of the option shares vest and become exercisable on May 2, 2012 and the remaining shares vest in 3 equal annual installments thereafter.